E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 7/8/2009 in the Prospect News PIPE Daily.

New Issue: NovaRay Medical settles $4.25 million private placement of convertibles

By Devika Patel

Knoxville, Tenn., July 8 - NovaRay Medical, Inc. raised $4.25 million in a private placement of 12% convertible bridge notes on July 2, according to an 8-K filed Wednesday with the Securities and Exchange Commission.

Vision Opportunity Master Fund, Ltd. bought $2.75 million of the notes.

The notes mature on Dec. 31, 2009. They are convertible into common shares at $2.67 per share.

Investors also received warrants for 1.5 million common shares, which are exercisable at $2.67 until July 2, 2014.

NovaRay is a private medical device company based in Newark, Calif.

Issuer:NovaRay Medical, Inc.
Issue:Convertible bridge notes
Amount:$4.25 million
Maturity:Dec. 31, 2009
Coupon:12%
Price:Par
Yield:12%
Conversion price:$2.67
Warrants:For 1.5 million shares
Warrant expiration:July 2, 2014
Warrant strike price:$2.67
Investor:Vision Opportunity Master Fund, Ltd. (for $2.75 million)
Settlement date:July 2

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.